Business · 06/06/2005
FDA Releases Draft Guidance on Safety Testing of Drug Metabolites
The Food and Drug Administration (FDA) has made available a draft guidance document titled 'Safety Testing of Drug Metabolites' that provides recommendations for assessing the safety of unique or major human metabolites of small molecule drugs under development.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →